Jianfeng Group Lin2016 -009 (Announcement of Mutual Guarantee with Zhejiang Kane)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2016-009
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd. on Mutual Guarantee between
and Zhejiang Kane Special Materials Co., Ltd.
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Tips
● Name of Guaranteed Party: Zhejiang Kane Special Materials Co., Ltd. (hereinafter referred to as Kane Stock)
● Quantity of this guarantee: RMB 5000 Yuan
● Is there any counter-guarantee in this guarantee: this guarantee is subject to equal mutual guarantee
● Cumulative number of overdue external guarantees: no
1. guarantee overview
April 8, 2016 Zhejiang Jianfeng Group Co., Ltd. held the sixth meeting of the 9th Board of Directors, and all eight directors of the company attended the meeting in person; comply with the relevant provisions of the "Company Law" and the "Articles of Association", and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the proposal of mutual guarantee with Zhejiang Kane Special Materials Co., Ltd. was deliberated and passed with 8 votes in favor, 0 against and 0 abstention.
agreed to implement a mutual guarantee with Kane shares of 5000 yuan for a period of one year. The external guarantee matters shall be submitted to the general meeting of shareholders for consideration.
2. basic information of the guarantor
1 , name of the guarantor: Zhejiang Kane Special Materials Co., Ltd. (hereinafter referred to as Kane shares).
2 , date of establishment: January 23, 1998 .
3 , listing: 2004# listed on Shenzhen stock exchange on July 5, 71, stock code: 002012.
4, domicile: No. 76, 1008 Kane Road, Suichang County, Zhejiang Province. 5
, registered capital: 46762.55yuan. Legal representative: Ji Hao. 6
. Business scope: manufacturing, processing and sales of electronic materials, paper and paper products; papermaking raw materials, etc.7
, relationship with the company: there is no relationship with the company. Financial situation ofKane shares: the company disclosed its annual report on March 29, 2016
. as of the end of 2015, the audited total assets were 1623.8619 million yuan and the total liabilities were 376.1424 million yuan, of which the total bank loans were 177.2111 million yuan, the total current liabilities were 357.7157 million yuan, and the total 118005.02 attributable to the owner's equity of the parent company was 960000 yuan. In 2015, the operating income was 892.5006 million yuan and the net profit was 19.3002 million yuan. Kane shares disclosed the "suggestive announcement of changes in the shareholding structure of controlling shareholders and changes in actual controllers" on April 8, 2016 . Announcement disclosure:
1 , 2016 On April 6,, the company's controlling shareholder Kane Group Co., Ltd. Shareholders Wang Bailang and Zhejiang Kelang Energy Co., Ltd. and Suzhou Hengyu Liuhe Investment Partnership (Limited Partnership) (hereinafter referred to as "Suzhou Hengyu") signed the "Equity Transfer Agreement", the agreement stipulates that Suzhou Hengyu will be transferred to 50% of Kane Group Co., Ltd. held by Wang Bailang and 40% of Kane Group Co., Ltd. held by Zhejiang Kelang Energy Co., Ltd.
2 . After the completion of this equity transfer, Suzhou Hengyu will hold 90% of Kane Group Co., Ltd. and become the controlling shareholder of Kane Group Co., Ltd. Natural person Cai Yang is the general partner and executive partner of Suzhou Hengyu, and actually controls Suzhou Hengyu. As a result, the actual controller of the company was changed from Wang Bailang and Wang Wenwei to Cai Yang.
On the same day, the information disclosure obligor: Suzhou Hengyu Liuhe Investment Partnership (Limited Partnership disclosed the "Detailed Equity Change Report". The report stated: "As of the date of signing this report, information disclosure The obligor has no specific plans to change the main business of the listed company or make major adjustments to the main business of the listed company. However, in order to enhance the sustainable development ability and profitability of listed companies, improve the asset quality of listed companies, and promote the long-term and healthy development of listed companies, we do not rule out the possibility of restructuring the company's assets and business in the next 12 months." And "the information disclosure obligor promises to perform the corresponding legal procedures and obligations in accordance with the requirements of relevant laws and regulations." The main content of
3. guarantee
company plans to carry out mutual guarantee with Kane shares in an amount of 5000.21 million yuan for a period of one year. Kane shares held the 23rd meeting of the sixth board of directors on March 25, 2016, and deliberated and passed the proposal on mutual guarantee with Zhejiang Jianfeng Group Co., Ltd. on April 22, 2016, Kane shares will hold the 2015 annual general meeting of shareholders to consider the proposal.
4. Board Opinion
Kane is a listed company with transparent financial information, good financial condition and the ability to repay debts. According to the announcement of Kane shares on April 8, 2016and the detailed equity change report disclosed by Suzhou Hengyu Liuhe Investment Partnership, the above-mentioned change of actual controller will not lead to significant changes in Kane's main business and financial situation in the short term. If there is any change, it is also to "enhance the sustainable development ability and profitability of listed companies and improve the asset quality of listed companies, to promote the long-term and healthy development of listed companies" for the purpose.
Board of Directors agreed to mutual insurance with them. The three independent directors of the company expressed their independent opinions on the matter and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.
5. Cumulative Number of External Guarantees and Number of Overdue GuaranteesAs of the disclosure date of this announcement, the total amount of external guarantees approved by the company and its controlling subsidiaries is 12.5
.8 billion yuan, accounting for 57.7 of the total owner's equity attributable to the parent company in 2015. Among them, the total amount of the approved guarantee for the holding subsidiary is 650 million yuan, accounting for 30.01 of the total owner's equity attributable to the parent company's audited consolidated caliber in 2015.
As of the disclosure date of this announcement, the actual balance of external guarantees of the company and its controlling subsidiaries (excluding subsidiaries) was 6.25 .2 billion yuan, accounting for 28.85 of the total owner's equity attributable to the parent company audited by the company in 2015. The actual balance of the company's guarantee to the controlling subsidiary is 25 million yuan, accounting for 1.15 of the company's total equity attributable to the parent company's audited consolidated caliber in 2015.
As of the disclosure date of this announcement, the company has no overdue guarantee.
6. Reference Document Catalogue1
, Resolution of the Sixth Meeting of the Ninth Board of Directors of the Company;
2 , photocopy of the guaranteed person's business license;
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of DirectorsApril 12, 2016
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31